BRIEF-Fennec Pharmaceuticals qtrly loss per share $0.05

* Fennec provides corporate update and announces fiscal year ended december 31, 2015 financial results
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.